RNS Number : 4413N
Keywords Studios PLC
18 January 2019
 

18 January 2019

 

 

Keywords Studios plc ("Keywords", "the Group")

                                                                                                                                               

Issue of Shares

 

Keywords Studios, the international technical services provider to the global video games industry, announces that 251,243 new ordinary shares have been issued to the vendors of Sperasoft in respect of the non-contingent deferred share consideration due to them.  

 

Since acquisition, the shares to be issued relating to the Sperasoft acquisition have been represented in the reported earnings per share numbers through the basic and diluted weighted average denominators used.  There are no further payments of shares or cash due to the vendors of Sperasoft.

 

Application has been made to the London Stock Exchange for the admission of 251,243 new ordinary shares to trading on AIM.  Admission of the new shares is expected to take place at 8:00am on 21 January 2019.  The Company's total issued share capital following admission will consist of 64,039,529 ordinary shares of one pence each with one voting right per share. The above figure of 64,039,529 may be used by shareholders as the denominator for the calculations by which they can determine if they are required to notify their interest in, or a change to their interest in, the Company following admission.

 

For further information, please contact:

Keywords Studios (www.keywordsstudios.com)

Andrew Day, Chief Executive Officer

David Broderick, Chief Financial Officer

+353 190 22 730

 

Numis (Financial Adviser)

Stuart Skinner / Kevin Cruickshank (Nominated Adviser)

James Black / Tom Ballard (Corporate Broker)

 

020 7260 1000

 

MHP Communications (Financial PR)

Katie Hunt / Ollie Hoare

 

 

020 3128 8771

keywords@mhpc.com

 


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
IOEBIGDBIGBBGCR